Cynata Therapeutics Ltd
F:51S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cynata Therapeutics Ltd
F:51S
|
AU |
|
B
|
Bristow Group Inc
F:ERG1
|
US |
|
A
|
Autolus Therapeutics PLC
F:6A3A
|
UK |
|
Taiyo Yuden Co Ltd
TSE:6976
|
JP |
|
Count Ltd
ASX:CUP
|
AU |
|
Algoma Central Corp
F:ACH
|
CA |
|
L
|
Livium Ltd
F:3MW
|
AU |
|
I
|
Ingenia Communities Group
OTC:INGEF
|
AU |
|
K
|
KBI Metal Co Ltd
KOSDAQ:024840
|
KR |
|
I
|
Innoviz Technologies Ltd
NASDAQ:INVZ
|
IL |
|
M
|
Mota Engil SGPS SA
SWB:M09
|
PT |
|
F
|
FirstGroup PLC
OTC:FGROY
|
UK |
|
B
|
Budweiser Brewing Company APAC Ltd
OTC:BDWBF
|
HK |
|
Optimus Group Co Ltd
OTC:OPTGF
|
JP |
|
OPTeam SA
F:7GS
|
PL |
|
Toubani Resources Inc
ASX:TRE
|
CA |
|
S
|
Sidma Steel SA
ATHEX:SIDMA
|
GR |
|
S
|
State Bank of India
SWB:SID
|
IN |
|
A
|
Agriauto Industries Ltd
KAR:AGIL
|
PK |
|
F
|
First Horizon Corp
F:FT2
|
US |
Bankruptcy Probability
Cynata Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cynata Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Cynata Therapeutics Ltd
ASX:CYP
|
3.2m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cynata Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cynata Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.